Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (13507)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Sep 7, 2019 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Tourkochristou E, Aggeletopoulou I, Konstantakis C, Triantos C. Role of NLRP3 inflammasome in inflammatory bowel diseases. World J Gastroenterol 2019; 25(33): 4796-4804 [PMID: 31543674 DOI: 10.3748/wjg.v25.i33.4796] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i33/4796.htm |
| Number | Citing Articles |
| 1 |
Yuxin Lin, Zibo Li, Yicheng Wang, Tian Tian, Penghui Jia, Yu Ye, Miao He, Zixiao Yang, Chunmei Li, Deyin Guo, Panpan Hou. CCDC50 suppresses NLRP3 inflammasome activity by mediating autophagic degradation of NLRP3. EMBO reports 2022; 23(5) doi: 10.15252/embr.202154453
|
| 2 |
Darshan Badal, Naresh Sachdeva, Deep Maheshwari, Preetam Basak. Role of nucleic acid sensing in the pathogenesis of type 1 diabetes. World Journal of Diabetes 2021; 12(10): 1655-1673 doi: 10.4239/wjd.v12.i10.1655
|
| 3 |
Esraa Abdel-Nassir Abdel-Razek, Heba M. Mahmoud, Amany A. Azouz. Management of ulcerative colitis by dichloroacetate: Impact on NFATC1/NLRP3/IL1B signaling based on bioinformatics analysis combined with in vivo experimental verification. Inflammopharmacology 2024; 32(1): 667 doi: 10.1007/s10787-023-01362-2
|
| 4 |
Sheng Gao, Yichen Li, Dingfeng Wu, Na Jiao, Li Yang, Rui Zhao, Zhifeng Xu, Wanning Chen, Xutao Lin, Sijing Cheng, Lixin Zhu, Ping Lan, Ruixin Zhu. IBD Subtype-Regulators IFNG and GBP5 Identified by Causal Inference Drive More Intense Innate Immunity and Inflammatory Responses in CD Than Those in UC. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.869200
|
| 5 |
Kanika Suri, Jason A. Bubier, Michael V. Wiles, Leonard D. Shultz, Mansoor M. Amiji, Vishnu Hosur. Role of MicroRNA in Inflammatory Bowel Disease: Clinical Evidence and the Development of Preclinical Animal Models. Cells 2021; 10(9): 2204 doi: 10.3390/cells10092204
|
| 6 |
Valentina Arrè, Rosanna Scialpi, Matteo Centonze, Gianluigi Giannelli, Maria Principia Scavo, Roberto Negro. The ‘speck’-tacular oversight of the NLRP3-pyroptosis pathway on gastrointestinal inflammatory diseases and tumorigenesis. Journal of Biomedical Science 2023; 30(1) doi: 10.1186/s12929-023-00983-7
|
| 7 |
Fei Zhang, Tong Meng, Rui Feng, Chen Jin, Song Zhang, Jialin Meng, Meng Zhang, Chaozhao Liang. MIF aggravates experimental autoimmune prostatitis through activation of the NLRP3 inflammasome via the PI3K/AKT pathway. International Immunopharmacology 2024; 141: 112891 doi: 10.1016/j.intimp.2024.112891
|
| 8 |
Marwa S. Serrya, Ahmed R. El-Sheakh, Mirhan N. Makled. Evaluation of the therapeutic effects of mycophenolate mofetil targeting Nrf-2 and NLRP3 inflammasome in acetic acid induced ulcerative colitis in rats. Life Sciences 2021; 271: 119154 doi: 10.1016/j.lfs.2021.119154
|
| 9 |
Yuxin Dai, Peiyi Li, Junyu Zhu, Jiaxin Jiang, weiwei tao, Tong Zhao, Yue Hu, Kang Ding, Min Zhao. Xianglian Pill Attenuates Ulcerative Colitis Through TLR4/MyD88/NF-κB Signaling Pathway. SSRN Electronic Journal 2022; doi: 10.2139/ssrn.4167665
|
| 10 |
Yue Zhao, Yaxin Liang, Qiuhong Chen, Shijuan Shan, Guiwen Yang, Hua Li. The function of NLRP3 in anti-infection immunity and inflammasome assembly of common carp (Cyprinus carpio L.). Fish & Shellfish Immunology 2024; 145: 109367 doi: 10.1016/j.fsi.2024.109367
|
| 11 |
Yi Xu, Yanling Yang, Xi Chen, Danling Jiang, Fei Zhang, Yao Guo, Bin Hu, Guohai Xu, Shengliang Peng, Lidong Wu, Jialing Hu. NLRP3 inflammasome in cognitive impairment and pharmacological properties of its inhibitors. Translational Neurodegeneration 2023; 12(1) doi: 10.1186/s40035-023-00381-x
|
| 12 |
Pampa Pain, Francesca Spinelli, Gaia Gherardi. Mitochondrial Cation Signalling in the Control of Inflammatory Processes. International Journal of Molecular Sciences 2023; 24(23): 16724 doi: 10.3390/ijms242316724
|
| 13 |
Jiajia Zhang, Stefan Wirtz. Does Pyroptosis Play a Role in Inflammasome-Related Disorders?. International Journal of Molecular Sciences 2022; 23(18): 10453 doi: 10.3390/ijms231810453
|
| 14 |
Miroslav Harjacek. Immunopathophysiology of Juvenile Spondyloarthritis (jSpA): The “Out of the Box” View on Epigenetics, Neuroendocrine Pathways and Role of the Macrophage Migration Inhibitory Factor (MIF). Frontiers in Medicine 2021; 8 doi: 10.3389/fmed.2021.700982
|
| 15 |
Mi Eun Kim, Jun Sik Lee. Molecular Foundations of Inflammatory Diseases: Insights into Inflammation and Inflammasomes. Current Issues in Molecular Biology 2024; 46(1): 469 doi: 10.3390/cimb46010030
|
| 16 |
Lei Wang, Wen Li, Shuzhen Xin, Shuang Wu, Chenglu Peng, Hongyan Ding, Shibing Feng, Chang Zhao, Jinjie Wu, Xichun Wang. Soybean glycinin and β-conglycinin damage the intestinal barrier by triggering oxidative stress and inflammatory response in weaned piglets. European Journal of Nutrition 2023; 62(7): 2841 doi: 10.1007/s00394-023-03188-8
|
| 17 |
Zheng Wang, Simei Zhang, Ying Xiao, Wunai Zhang, Shuai Wu, Tao Qin, Yangyang Yue, Weikun Qian, Li Li. NLRP3 Inflammasome and Inflammatory Diseases. Oxidative Medicine and Cellular Longevity 2020; 2020: 1 doi: 10.1155/2020/4063562
|
| 18 |
Iuliana Samoilă, Sorina Dinescu, Marieta Costache. Interplay between Cellular and Molecular Mechanisms Underlying Inflammatory Bowel Diseases Development—A Focus on Ulcerative Colitis. Cells 2020; 9(7): 1647 doi: 10.3390/cells9071647
|
| 19 |
Ruiting Li, You Shang, Yuan Yu, Ting Zhou, Wei Xiong, Xiaojing Zou. High-mobility group box 1 protein participates in acute lung injury by activating protein kinase R and inducing M1 polarization. Life Sciences 2020; 246: 117415 doi: 10.1016/j.lfs.2020.117415
|
| 20 |
Yaning Biao, Jian Chen, Chenxu Liu, Ruilong Wang, Xue Han, Li Li, Yixin Zhang. Protective Effect of Danshen Zexie Decoction Against Non-Alcoholic Fatty Liver Disease Through Inhibition of ROS/NLRP3/IL-1β Pathway by Nrf2 Signaling Activation. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.877924
|
| 21 |
Tao Liu, Xuegang Wang, Feng Guo, Xiaobo Sun, Kunxiong Yuan, Qingyong Wang, Chunwei Lan. Lysophosphatidylcholine induces apoptosis and inflammatory damage in brain microvascular endothelial cells via GPR4-mediated NLRP3 inflammasome activation. Toxicology in Vitro 2021; 77: 105227 doi: 10.1016/j.tiv.2021.105227
|
| 22 |
Ji Zhang, Xue-jun Wang, Li-jie Wu, Ling Yang, Yan-ting Yang, Dan Zhang, Jue Hong, Xi-ying Li, Xiao-qing Dong, Xiao-cong Guo, Rong Han, Xiaopeng Ma, Jean Kanellopoulos. Herb-partitioned moxibustion alleviates colonic inflammation in Crohn’s disease rats by inhibiting hyperactivation of the NLRP3 inflammasome via regulation of the P2X7R-Pannexin-1 signaling pathway. PLOS ONE 2021; 16(5): e0252334 doi: 10.1371/journal.pone.0252334
|
| 23 |
Somnath Mazumder, Samik Bindu, Rudranil De, Subhashis Debsharma, Saikat Pramanik, Uday Bandyopadhyay. Emerging role of mitochondrial DAMPs, aberrant mitochondrial dynamics and anomalous mitophagy in gut mucosal pathogenesis. Life Sciences 2022; 305: 120753 doi: 10.1016/j.lfs.2022.120753
|
| 24 |
Yuxin Dai, Qiulu Lu, Peiyi Li, Junyu Zhu, Jiaxin Jiang, Tong Zhao, Yue Hu, Kang Ding, Min Zhao. Xianglian Pill attenuates ulcerative colitis through TLR4/MyD88/NF-κB signaling pathway. Journal of Ethnopharmacology 2023; 300: 115690 doi: 10.1016/j.jep.2022.115690
|
| 25 |
Yu Li, Yuanyuan Chen, Lili Jiang, Jingyu Zhang, Xuhui Tong, Dapeng Chen, Weidong Le. Intestinal Inflammation and Parkinson’s Disease. Aging and disease 2021; 12(8): 2052 doi: 10.14336/AD.2021.0418
|
| 26 |
Yi Huang, Wen Xu, Rongbin Zhou. NLRP3 inflammasome activation and cell death. Cellular & Molecular Immunology 2021; 18(9): 2114 doi: 10.1038/s41423-021-00740-6
|
| 27 |
Shanshan Liu, Tiantian Tang, Wei Liu, Min Chen, Kemin Qi, Xin Ni, Jie Zhang. NLRP3 Inflammasome Activation During Acute Negative Pressure Injury in the Middle Ear of Mice. Otology & Neurotology 2024; 45(4): e328 doi: 10.1097/MAO.0000000000004135
|
| 28 |
Roxana Zaharie, Dan Valean, Calin Popa, Alin Fetti, Claudiu Zdrehus, Aida Puia, Lia Usatiuc, Diana Schlanger, Florin Zaharie. The Multifaceted Role and Regulation of Nlrp3 Inflammasome in Colitis-Associated Colo-Rectal Cancer: A Systematic Review. International Journal of Molecular Sciences 2023; 24(4): 3472 doi: 10.3390/ijms24043472
|
| 29 |
Yue Zhao, Yinlian Yao, Shilong Fan, Xin Shen, Xingxing Chai, Zimin Li, Jiachun Zeng, Jiang Pi, Zhikun Zhou, Gonghua Huang, Hua Jin. Oral delivery of pH-sensitive nanoparticles loaded Celastrol targeting the inflammatory colons to treat ulcerative colitis. Journal of Tissue Engineering 2024; 15 doi: 10.1177/20417314241265892
|
| 30 |
Sameh Saber, Eslam E. Abd El-Fattah, Galal Yahya, Naglaa A. Gobba, Abdalkareem Omar Maghmomeh, Ahmed E. Khodir, Ahmed A. E. Mourad, Ahmed S. Saad, Hager G. Mohammed, Nehal A. Nouh, Ahmed Shata, Noha A. Amin, Magdy Abou El-Rous, Samuel Girgis, Eman El-Ahwany, Eman M. Khalaf, Attalla F. El-Kott, Ahmed M. El-Baz. A Novel Combination Therapy Using Rosuvastatin and Lactobacillus Combats Dextran Sodium Sulfate-Induced Colitis in High-Fat Diet-Fed Rats by Targeting the TXNIP/NLRP3 Interaction and Influencing Gut Microbiome Composition. Pharmaceuticals 2021; 14(4): 341 doi: 10.3390/ph14040341
|
| 31 |
Francesca La Rosa, Ilaria Varotto-Boccazzi, Marina Saresella, Ivana Marventano, Giulia Maria Cattaneo, Ambra Hernis, Federica Piancone, Domenico Otranto, Sara Epis, Claudio Bandi, Mario Clerici. The non-pathogenic protozoon Leishmania tarentolae interferes with the activation of NLRP3 inflammasome in human cells: new perspectives in the control of inflammation. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1298275
|
| 32 |
Cédric Garcia, Baptiste Compagnon, Michaël Poëtte, Marie-Pierre Gratacap, François-Xavier Lapébie, Sophie Voisin, Vincent Minville, Bernard Payrastre, Fanny Vardon-Bounes, Agnès Ribes. Platelet Versus Megakaryocyte: Who Is the Real Bandleader of Thromboinflammation in Sepsis?. Cells 2022; 11(9): 1507 doi: 10.3390/cells11091507
|
| 33 |
Zhenyi Wang, Yitong Yang, Nisha Wang, Linhe Lu, Chennian Xu, Jun Ren, Lifang Yang. RIP3 orchestrates oxidative stress and pyroptosis in doxorubicin-induced cardiotoxicity through regulation of AKT/Nrf2 signaling cascade. Molecular and Cellular Biochemistry 2024; doi: 10.1007/s11010-024-05029-6
|
| 34 |
Xiaoxiao Sun, Haipeng Pang, Jiaqi Li, Shuoming Luo, Gan Huang, Xia Li, Zhiguo Xie, Zhiguang Zhou. The NLRP3 Inflammasome and Its Role in T1DM. Frontiers in Immunology 2020; 11 doi: 10.3389/fimmu.2020.01595
|
| 35 |
Na Lu, Weijia Cheng, Dongling Liu, Gang Liu, Can Cui, Chaoli Feng, Xianwei Wang. NLRP3-Mediated Inflammation in Atherosclerosis and Associated Therapeutics. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.823387
|
| 36 |
Xiaohu Zhao, Rui Feng, Juan Chen, Qing Jiang, Xiaoliang Hua, Chaozhao Liang. 4‐Octyl itaconate alleviates experimental autoimmune prostatitis by inhibiting the NLRP3 inflammasome‐induced pyroptosis through activating Nrf2/HO‐1 pathway. The Prostate 2024; 84(4): 329 doi: 10.1002/pros.24652
|
| 37 |
Xueming Xu, Jing Li, Xiuyan Long, Sifan Tao, Xiaoyu Yu, Xixian Ruan, Kai Zhao, Li Tian. C646 Protects Against DSS-Induced Colitis Model by Targeting NLRP3 Inflammasome. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.707610
|
| 38 |
Functionalized nanomaterials targeting NLRP3 inflammasome driven immunomodulation: Friend or Foe. Nanoscale 2023; 15(39): 15906 doi: 10.1039/D3NR03857B
|
| 39 |
Ge Zhang, He Chen, Yifan Guo, Wei Zhang, Qiuyu Jiang, Si Zhang, Liping Han, She Chen, Ruyi Xue. Activation of Platelet NLRP3 Inflammasome in Crohn’s Disease. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.705325
|
| 40 |
Xinrui Gao, Xi Feng, Tao Hou, Wen Huang, Zhili Ma, Dexin Zhang. The roles of flavonoids in the treatment of inflammatory bowel disease and extraintestinal manifestations: A review. Food Bioscience 2024; 62: 105431 doi: 10.1016/j.fbio.2024.105431
|
| 41 |
Rui Liang, Wei Chen, Huining Fan, Xiaoyu Chen, Jing Zhang, Jin-Shui Zhu. Dihydroartemisinin prevents dextran sodium sulphate-induced colitis through inhibition of the activation of NLRP3 inflammasome and p38 MAPK signaling. International Immunopharmacology 2020; 88: 106949 doi: 10.1016/j.intimp.2020.106949
|
| 42 |
Hongwen Liang, Kai Liu, Zhe Zhuang, Hong Sun, Bo Sun, Minna Jiao, Yeqian Cai, Guofeng Cai. Potential of Forsythoside I as a therapeutic approach for acute lung injury: Involvement of TXNIP/NLRP3 inflammasome. Molecular Immunology 2021; 134: 192 doi: 10.1016/j.molimm.2021.03.004
|
| 43 |
Tomofumi Oizumi, Taira Mayanagi, Yosuke Toya, Tamotsu Sugai, Takayuki Matsumoto, Kenji Sobue. NLRP3 Inflammasome Inhibitor OLT1177 Suppresses Onset of Inflammation in Mice with Dextran Sulfate Sodium-Induced Colitis. Digestive Diseases and Sciences 2022; 67(7): 2912 doi: 10.1007/s10620-021-07184-y
|
| 44 |
Ming-Yu Jin, Xiao-Yong Wu, Mei-Ying Li, Hao Deng, Ri-Ming Huang, Yuan-Ming Sun, Cheol-Heui Yun, Zhen-Lin Xu. Noni (Morinda citrifolia L.) Fruit Polysaccharide Attenuated Inflammatory Bowel Disease Mice: Association of STAT3/NLRP3 Signaling Pathways. ACS Food Science & Technology 2023; 3(11): 1965 doi: 10.1021/acsfoodscitech.3c00351
|
| 45 |
Euni Cho, Seok-Jun Mun, Hyo Keun Kim, Yu Seong Ham, Woo Jin Gil, Chul-Su Yang. Colon-targeted S100A8/A9-specific peptide systems ameliorate colitis and colitis-associated colorectal cancer in mouse models. Acta Pharmacologica Sinica 2024; 45(3): 581 doi: 10.1038/s41401-023-01188-2
|
| 46 |
Jincheng Tan, Shumeng Wang, Shu Gan, Hui Chen, Keying Zhong, HiuYee Kwan, Xueying Fan, Bixia Xiao, Qi Liang, Zhongqiu Liu, Tao Su. Centipeda minima (L.) A. Braun & Asch. and its representative active compound alleviate DSS-induced ulcerative colitis via inhibition of NLRP3 inflammasome activation and regulation of gut microbiota. Journal of Functional Foods 2024; 117: 106207 doi: 10.1016/j.jff.2024.106207
|
| 47 |
Deirdre O'Sullivan, Michael Moore, Susan Byrne, Andreas O. Reiff, Susanna Felsenstein. Anti-Myelin Oligodendrocyte Glycoprotein Encephalomyelitis and Extensive Longitudinal Transverse Myelitis Associated with Compound Heterozygous NLRP3 Missense Mutations in a Young Child. Journal of Pediatric Neurology 2021; 19(05): 359 doi: 10.1055/s-0040-1721434
|
| 48 |
Sanzida Jahan, Nidaa Awaja, Bradley Hess, Stephanie Hajjar, Subash Sad, David Lohnes. The transcription factor Cdx2 regulates inflammasome activity through expression of the NLRP3 suppressor TRIM31 to maintain intestinal homeostasis. Journal of Biological Chemistry 2022; 298(10): 102386 doi: 10.1016/j.jbc.2022.102386
|
| 49 |
Zhenzhen Fang, Huangan Wu, Luyi Wu, Yanan Liu, Ling Yang, Chen Zhao, Zhe Ma, Yan Huang, Wenjia Wang. Exploring the mechanism by which acupuncture and moxibustion reduce colonic mucosal inflammation in rats with ulcerative colitis (UC) based on the P2X7R-NLRP3 inflammasome pathway. Journal of Acupuncture and Tuina Science 2023; 21(5): 356 doi: 10.1007/s11726-023-1364-6
|
| 50 |
Burak Ibrahim Arioz, Emre Tarakcioglu, Melis Olcum, Sermin Genc. The Role of Melatonin on NLRP3 Inflammasome Activation in Diseases. Antioxidants 2021; 10(7): 1020 doi: 10.3390/antiox10071020
|
| 51 |
Shengyang Xiao, Xiaoning Song, Man Zheng, Xinran Cao, Guo Ai, Baona Li, Gang Zhao, Haitao Yuan. Interleukin-37 ameliorates atherosclerosis by regulating autophagy-mediated endothelial cell apoptosis and inflammation. International Immunopharmacology 2023; 118: 110098 doi: 10.1016/j.intimp.2023.110098
|
| 52 |
Ya Wang, Zhengyang Zhang, Hui Li, Min Wang, Yuting Qiu, Lili Lu. miR-29b-3p regulates cardiomyocytes pyroptosis in CVB3-induced myocarditis through targeting DNMT3A. Cellular & Molecular Biology Letters 2024; 29(1) doi: 10.1186/s11658-024-00576-8
|
| 53 |
Barbara Klughammer, Luca Piali, Alexandra Nica, Sandra Nagel, Lorna Bailey, Christoph Jochum, Stanislav Ignatenko, Angela Bläuer, Sabrina Danilin, Pratiksha Gulati, Joanne Hayward, Petar Scepanovic, Jitao David Zhang, Satish Bhosale, Chui Fung Chong, Andreas Christ. A randomized, double‐blind phase 1b study evaluating the safety, tolerability, pharmacokinetics and pharmacodynamics of the NLRP3 inhibitor selnoflast in patients with moderate to severe active ulcerative colitis. Clinical and Translational Medicine 2023; 13(11) doi: 10.1002/ctm2.1471
|
| 54 |
Uttam Kulhari, Sourav Kundu, Madhav Nilakanth Mugale, Bidya Dhar Sahu. Nuciferine alleviates intestinal inflammation by inhibiting MAPK/NF-κB and NLRP3/Caspase 1 pathways in vivo and in vitro. International Immunopharmacology 2023; 115: 109613 doi: 10.1016/j.intimp.2022.109613
|
| 55 |
Alireza Shadab, Mohamad Mahjoor, Mohammad Abbasi-Kolli, Hamed Afkhami, Parisa Moeinian, Amir-Reza Safdarian. Divergent functions of NLRP3 inflammasomes in cancer: a review. Cell Communication and Signaling 2023; 21(1) doi: 10.1186/s12964-023-01235-9
|
| 56 |
Yue Yang, Pan Gong, Xiuyan Long, Yuanjuan Jiang, Mingmei Ye, Sifan Tao, Yahui Su, Fei Yang, Li Tian. Microcystin-LR Induces and Aggravates Colitis through NLRP3 Inflammasome-Mediated Pyroptosis in Mice. Toxins 2023; 15(7): 447 doi: 10.3390/toxins15070447
|
| 57 |
Xiu Cai, Zhi-yu Zhang, Jin-tao Yuan, Dickson Kofi Wiredu Ocansey, Qiang Tu, Xu Zhang, Hui Qian, Wen-rong Xu, Wei Qiu, Fei Mao. hucMSC-derived exosomes attenuate colitis by regulating macrophage pyroptosis via the miR-378a-5p/NLRP3 axis. Stem Cell Research & Therapy 2021; 12(1) doi: 10.1186/s13287-021-02492-6
|
| 58 |
Ming Fu, Nini Chen, Yanhe Zhou, Sidong Chen, Wanfu Xu, Sitang Gong, Lanlan Geng. Jatrorrhizine Suppresses Murine-Norovirus-Triggered N-GSDMD-Dependent Pyroptosis in RAW264.7 Macrophages. Vaccines 2023; 11(1): 164 doi: 10.3390/vaccines11010164
|
| 59 |
Yuichi Yamasaki, Tomohiro Kubota, Syuji Takei, Hiroyuki Imanaka, Yukiko Nonaka, Yoshifumi Kawano. A case of cryopyrin-associated periodic fever syndrome during canakinumab administration complicated by inflammatory bowel disease. Clinical Rheumatology 2021; 40(1): 393 doi: 10.1007/s10067-020-05267-1
|
| 60 |
Yue Sun, Yun Guo, Jing Zhang, Lihua Chang, Haiyan Zhao, Xiaofei Wang, Jagadeesh Bayry. Sparstolonin B Exerts Therapeutic Effects on Collagen-Induced Arthritis by Inhibiting the NLRP3 Inflammasome and Reducing the Activity of α1,3-Fucosyltransferase. Mediators of Inflammation 2021; 2021: 1 doi: 10.1155/2021/8145412
|
| 61 |
Hossein Pazoki, Hamed Mirjalali, Maryam Niyyati, Seyed Javad Seyed Tabaei, Nariman Mosaffa, Shabnam Shahrokh, Hamid Asadzadeh Ahdaei, Andreas Kupz, Mohammad Reza Zali. Toxoplasma gondii profilin induces NLRP3 activation and IL-1β production/secretion in THP-1 cells. Microbial Pathogenesis 2023; 180: 106120 doi: 10.1016/j.micpath.2023.106120
|
| 62 |
Xueming Xu, Yuanfeng Han, Jiali Deng, Shengfeng Wang, Shijie Zhuo, Kai Zhao, Wenhu Zhou. Repurposing disulfiram with CuET nanocrystals: Enhancing anti-pyroptotic effect through NLRP3 inflammasome inhibition for treating inflammatory bowel diseases. Acta Pharmaceutica Sinica B 2024; 14(6): 2698 doi: 10.1016/j.apsb.2024.03.003
|
| 63 |
Sharmim Sultana, Thanh Doan Viet, Tasmiha Amin, Esha Kazi, Luigina Micolucci, Abul Kalam Mohammad Moniruzzaman Mollah, Most Mauluda Akhtar, Md Soriful Islam. Exploring Inflammasome Complex as a Therapeutic Approach in Inflammatory Diseases. Future Pharmacology 2023; 3(4): 789 doi: 10.3390/futurepharmacol3040048
|
| 64 |
Xiaorong Hou, Guang Xu, Zhilei Wang, Xiaoyan Zhan, Huifang Li, Ruisheng Li, Wei Shi, Chunyu Wang, Yuanyuan Chen, Yongqiang Ai, Xiaohe Xiao, Zhaofang Bai. Glaucocalyxin A alleviates LPS-mediated septic shock and inflammation via inhibiting NLRP3 inflammasome activation. International Immunopharmacology 2020; 81: 106271 doi: 10.1016/j.intimp.2020.106271
|
| 65 |
Ioanna Aggeletopoulou, Maria Kalafateli, Efthymios P. Tsounis, Christos Triantos. Exploring the role of IL-1β in inflammatory bowel disease pathogenesis. Frontiers in Medicine 2024; 11 doi: 10.3389/fmed.2024.1307394
|
| 66 |
Yichen Li, Xutao Lin, Wenxia Wang, Wenyu Wang, Sijing Cheng, Yibo Huang, Yifeng Zou, Jia Ke, Lixin Zhu. The Proinflammatory Role of Guanylate-Binding Protein 5 in Inflammatory Bowel Diseases. Frontiers in Microbiology 2022; 13 doi: 10.3389/fmicb.2022.926915
|
| 67 |
Yuan Yao, Yongchao Liu, Qiuyun Xu, Liming Mao. Short Chain Fatty Acids: Essential Weapons of Traditional Medicine in Treating Inflammatory Bowel Disease. Molecules 2024; 29(2): 379 doi: 10.3390/molecules29020379
|